# Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients of Different Ages With Metastatic Breast Cancer

> **NCT00609791** · PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **City of Hope Medical Center** · enrollment: 40 (actual)

## Conditions studied

- Breast Cancer

## Interventions

- **DRUG:** paclitaxel albumin-stabilized nanoparticle formulation
- **OTHER:** pharmacological study
- **OTHER:** physiologic testing
- **OTHER:** questionnaire administration
- **OTHER:** study of socioeconomic and demographic variables
- **PROCEDURE:** cognitive assessment
- **PROCEDURE:** psychosocial assessment and care

## Key facts

- **NCT ID:** NCT00609791
- **Lead sponsor:** City of Hope Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2008-02-11
- **Primary completion:** 2011-10-25
- **Final completion:** 2026-04-24
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2025-06-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00609791

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00609791, "Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients of Different Ages With Metastatic Breast Cancer". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00609791. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*